BRPI0309001A2 - bactérias gram-negativas atenuadas - Google Patents

bactérias gram-negativas atenuadas

Info

Publication number
BRPI0309001A2
BRPI0309001A2 BRPI0309001A BRPI0309001A BRPI0309001A2 BR PI0309001 A2 BRPI0309001 A2 BR PI0309001A2 BR PI0309001 A BRPI0309001 A BR PI0309001A BR PI0309001 A BRPI0309001 A BR PI0309001A BR PI0309001 A2 BRPI0309001 A2 BR PI0309001A2
Authority
BR
Brazil
Prior art keywords
bacterium
negative bacteria
mutant
attenuated gram
disclosed
Prior art date
Application number
BRPI0309001A
Other languages
English (en)
Inventor
Xaver Legros Francos
Rachel Crooke Helen
Elzabeth Shea Jacquelne
Graham Feldman Robert
Gabrel Coutebroze Sylvan
Original Assignee
Meral Lmted
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meral Lmted filed Critical Meral Lmted
Publication of BRPI0309001A2 publication Critical patent/BRPI0309001A2/pt
Publication of BRPI0309001B1 publication Critical patent/BRPI0309001B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0309001-9A 2002-04-05 2003-04-04 Bactérias gram-negativas atenuadas BRPI0309001B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37028202P 2002-04-05 2002-04-05
US60/370,282 2002-04-05
US10/406,686 2003-04-03
US10/406,686 US7449178B2 (en) 2002-04-05 2003-04-03 Attenuated gram negative bacteria
PCT/US2003/010308 WO2003086277A2 (en) 2002-04-05 2003-04-04 Attenuated gram negative bacteria

Publications (2)

Publication Number Publication Date
BRPI0309001A2 true BRPI0309001A2 (pt) 2017-07-04
BRPI0309001B1 BRPI0309001B1 (pt) 2021-11-30

Family

ID=29254405

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0309001-9A BRPI0309001B1 (pt) 2002-04-05 2003-04-04 Bactérias gram-negativas atenuadas

Country Status (15)

Country Link
US (3) US7449178B2 (pt)
EP (1) EP1575483B1 (pt)
JP (1) JP4338528B2 (pt)
KR (1) KR101037566B1 (pt)
CN (2) CN102864090A (pt)
AT (1) ATE518955T1 (pt)
AU (2) AU2003223447C1 (pt)
BR (1) BRPI0309001B1 (pt)
CA (1) CA2481186C (pt)
CO (1) CO5640065A1 (pt)
ES (1) ES2371498T3 (pt)
MX (1) MXPA04009730A (pt)
NZ (1) NZ535993A (pt)
PT (1) PT1575483E (pt)
WO (1) WO2003086277A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060099543A (ko) * 1994-12-09 2006-09-19 임페리얼 컬리지 이노베이션스 리미티드 유전자의 동정
PT1108034E (pt) * 1998-09-04 2008-11-14 Emergent Product Dev Uk Ltd Mutantes de spi2 de salmonela atenuados como transportadores de antigénios
GB9910812D0 (en) * 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
DK1350796T3 (da) * 2002-04-05 2009-03-02 Merial Sas Attenuerede gramnegative bakterier
DE602004003582T2 (de) 2003-07-02 2007-09-20 Biotechnology Research And Development Corp., Peoria Akapsuläre i p. multocida hyae deletionsmutanten
KR20070092290A (ko) * 2004-12-22 2007-09-12 인터벳 인터내셔널 비.브이. 파스퇴렐라 멀토시다 백신
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
US8917497B2 (en) * 2012-07-23 2014-12-23 Knaack Llc Jobsite storage cabinet for housing electronic equipment
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
CN107075562B (zh) * 2014-09-30 2021-09-24 深圳华大基因科技有限公司 用于肥胖症相关疾病的生物标记物
WO2022072431A1 (en) * 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions
TW202219269A (zh) * 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
CN116144565B (zh) * 2022-12-21 2025-09-26 四川农业大学 减毒多杀性巴氏杆菌及其构建方法和应用
CN117534732B (zh) * 2023-11-03 2024-10-22 湖南中晟全肽生物科技股份有限公司 一种抑制il-12与其受体结合的多肽及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668779A4 (en) * 1992-11-06 1996-08-21 Univ Minnesota Vaccine to protect against pasteurellosis - infection by P.multocida.
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
KR20060099543A (ko) 1994-12-09 2006-09-19 임페리얼 컬리지 이노베이션스 리미티드 유전자의 동정
CA2206575A1 (en) * 1996-05-31 1997-11-30 Akzo Nobel Nv Live attenuated rtx-producing bacteria of the family pasteurellaceae
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
US6783764B1 (en) * 1997-04-10 2004-08-31 Akzo Nobel Nv Actinobacillus pleuropneumoniae subunit vaccine
CH692179A5 (de) 1997-06-25 2002-03-15 Kueschall Design Ag Rollstuhl und Sitzmodul für den Rollstuhl,
US20010018055A1 (en) * 1997-09-25 2001-08-30 Briggs Robert E. Deletion mutants of virulence factors of pasteurellaceae
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
CA2366520C (en) * 1999-04-09 2013-10-01 Zoetis Services Llc Anti-bacterial vaccine compositions
GB9910812D0 (en) * 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
US6780405B1 (en) * 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)
WO2002018601A2 (en) * 2000-08-25 2002-03-07 Abbott Laboratories Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes'
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
DK1350796T3 (da) * 2002-04-05 2009-03-02 Merial Sas Attenuerede gramnegative bakterier
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
EP1608676A2 (en) * 2003-03-27 2005-12-28 Children's Hospital, Inc. Nontypeable haemophilus influenzae virulence factors
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
TWI328458B (en) * 2007-03-09 2010-08-11 Univ Nat Chunghsing Subunit vaccine of pasteurella multocida in veterinary uses

Also Published As

Publication number Publication date
WO2003086277A2 (en) 2003-10-23
AU2010206113B2 (en) 2012-03-15
CN1934240A (zh) 2007-03-21
US8329163B2 (en) 2012-12-11
ES2371498T3 (es) 2012-01-03
ATE518955T1 (de) 2011-08-15
US7449178B2 (en) 2008-11-11
PT1575483E (pt) 2011-09-08
AU2003223447A1 (en) 2003-10-27
AU2003223447C1 (en) 2011-01-06
NZ535993A (en) 2010-02-26
MXPA04009730A (es) 2006-04-28
JP4338528B2 (ja) 2009-10-07
CA2481186A1 (en) 2003-10-23
AU2003223447B2 (en) 2010-06-03
EP1575483B1 (en) 2011-08-03
KR101037566B1 (ko) 2011-05-27
AU2010206113A1 (en) 2010-08-26
CA2481186C (en) 2015-10-06
JP2005535296A (ja) 2005-11-24
CN102864090A (zh) 2013-01-09
HK1078271A1 (en) 2006-03-10
CO5640065A1 (es) 2006-05-31
US20090252766A1 (en) 2009-10-08
EP1575483A2 (en) 2005-09-21
BRPI0309001B1 (pt) 2021-11-30
EP1575483A4 (en) 2007-07-04
KR20050016334A (ko) 2005-02-21
US20120009218A1 (en) 2012-01-12
US20040033586A1 (en) 2004-02-19
WO2003086277A9 (en) 2006-02-23
US7943125B2 (en) 2011-05-17
WO2003086277A3 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
BRPI0309001A2 (pt) bactérias gram-negativas atenuadas
WO2002062378A3 (en) Hyperblebbing bacterial strains and use thereof for production of vaccines
PT721506E (pt) Proteinas exportadas bacterianas e vacinas acelulares baseadas nestas
MX9705727A (es) Variantes de amilasa.
GEP20032977B (en) Proteinase K-Resistant Surface Protein of Neisseria Meningitidis
ATE347591T1 (de) Thermostabile alpha-amylase
IL142231A0 (en) Mutant cholera holotoxin as an adjuvant
GB0202556D0 (en) Novel Protein
ES2535961T3 (es) Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
Sauerborn et al. Nucleotide sequence of Clostridium difficile toxin A
CY1108972T1 (el) Εξασθενημενα αρνητικα κατα gram βακτηρια
DE69836520D1 (de) Clostridium perfringens Impfstoff
IL175319A (en) Phosphorus-related protein, preparations containing @ the same L @ use @ it @ and method @ to identify it
NZ526879A (en) Genes and proteins, and their use
ATE452184T1 (de) Mikrobielle trypsinvarianten mit chymotrypsinaktivität und diese codierende nukleinsäuren
BR9506038A (pt) Dna clonato vetor recombinante e planta
TW200716166A (en) Lawsonia intracellularis immunological proteins
IL156041A0 (en) Nucleic acid adjuvants
KR930013104A (ko) 세르풀리나 하이오다이센테리애 백신
Torelli et al. Draft genome of a Xanthomonas perforans strain associated with pith necrosis
NZ511166A (en) Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B
NO20025126L (no) (R)-2-hydroksy-3-fenylpropionisk syre (D-fenylmelkesyre) dehydrogenase, oggen som koder for samme
GB9027901D0 (en) Acellular vaccine
DE60021707D1 (de) Beta-primeverosidase gen
WO2000046242A3 (en) 19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI)

Legal Events

Date Code Title Description
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]
B25A Requested transfer of rights approved

Owner name: MERIAL, INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/04/2003, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B25A Requested transfer of rights approved

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (US)

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 04/04/2023